The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
29-Jul-24
Undisclosed
Target:
APA Corporation Midland Basin Minerals and Royalties Interests
Acquiror:
Post Oak Energy Capital, LP
Advised Post Oak Energy Capital, a Houston-based, energy-focused private equity firm, on the acquisition of Midland Basin Minerals and Royalties Assets from APA Corporation, an independent oil and gas producer
01-Jul-24
Undisclosed
Target:
Medical Review Institute of America
Acquiror:
Parthenon Capital
Advised Medical Review Institute of America, a portfolio company of Summit Partners and a leading provider of outsourced utilization management and clinical review solutions to payors, on its strategic growth investment from Parthenon Capital
26-Jun-24
Pending
$630 million
Target:
Haleon plc’s Nicotine Replacement Therapy Business (ex-US)
Acquiror:
Dr. Reddy’s Laboratories
Advising Haleon plc on the sale of its global nicotine replacement therapy business (ex-US) to Dr. Reddy’s Laboratories
24-Jun-24
$875 million
Target:
Durango Permian
Acquiror:
Kinetik Holdings
Advised Durango Midstream, an owner and operator of natural gas gathering & processing infrastructure, and Morgan Stanley Energy Partners (“MSEP”) on the sale of Durango Permian LLC to Kinetik Holdings Inc. (NYSE: KNTK), a premier midstream operator in the Delaware Basin
20-Jun-24
Pending
$1.8 billion
Target:
CP Kelco
Acquiror:
Tate & Lyle
Advising Tate & Lyle plc, a UK-listed specialty food and beverage ingredients company, on the acquisition of CP Kelco, a US-based provider of pectin, speciality gums and other nature-based ingredients, from J.M. Huber Corporation
08-May-24
$800 million
Target:
U.S. Acute Care Solutions
Advised U.S. Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on the refinancing of its senior secured notes
01-May-24
Undisclosed
Target:
Functional Formularies
Acquiror:
Danone
Advised Danone on its acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital
05-Feb-24
Pending
Undisclosed
Target:
Equity Interest in ARM Energy Trading
Acquiror:
Tokyo Gas America
Advising Tokyo Gas America on the acquisition of a 49% equity interest stake in ARM Energy Holding’s producer services and wholesale commodity trading business, ARM Energy Trading. Tokyo Gas America is an energy company that engages in a wide range of businesses, including operated gas and oil assets, midstream, downstream, power generation, natural gas distribution, and LNG exportation
15-Jan-24
Pending
$1.29 billion
Target:
QuarterNorth Energy Inc.
Acquiror:
Talos Energy Inc.
Advising Talos Energy, an independent exploration and production company, on the acquisition of QuarterNorth Energy, a privately held offshore Gulf of Mexico E&P operator with working interests in several prolific deepwater U.S. Gulf of Mexico assets
15-Dec-23
Pending
$2.7 billion
Target:
Rockcliff Energy II LLC
Acquiror:
TG Natural Resources
Advising TG Natural Resources on the acquisition of Rockcliff Energy II LLC, a portfolio company of Quantum Energy Partners (“Quantum”). Rockcliff is a premier natural gas company in the prolific East Texas Haynesville shale and one of the top natural gas producers in the state of Texas. TG Natural Resources is a Houston based, private E&P company with operations focused in the Haynesville Shale and majority owned by Tokyo Gas
13-Dec-23
Pending
Undisclosed
Target:
Vopak Moda Houston
Acquiror:
Exolum
Advising Exolum on its acquisition of 50% interest in Vopak Moda Houston, a leading ammonia and NGL storage & export terminal, from Moda Midstream (Encap Flatrock-Backed)
16-Nov-23
~$400 million
Target:
Sonoma-Cutrer Vineyards (Brown-Forman)
Acquiror:
The Duckhorn Portfolio
Advised Brown-Forman, the largest American-owned spirits and wine company, on its sale of Sonoma-Cutrer Vineyards to The Duckhorn Portfolio
14-Nov-23
Undisclosed
Target:
Minerals and Royalties Interest
Acquiror:
Undisclosed
Advised a company on the sale of its minerals and royalties interests in the Appalachian Basin
27-Sep-23
Undisclosed
Target:
Slayback Pharma LLC
Acquiror:
Azurity Pharmaceuticals
Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products
14-Jul-23
$674 million
Target:
Juice Plus+
Advised Juice Plus+, a global health and wellness company in the direct selling space on a comprehensive recapitalization transaction
01-Jun-23
Pending
Undisclosed
Target:
Interest in Joint Venture with CarepathRx Health System Solutions
Acquiror:
The Cigna Group
Advising Cigna on its investment in CarepathRx Health System Solutions, under Evernorth, Cigna’s health services subsidiary
16-Feb-23
Pending
$220 million
Target:
Flavor Specialty Ingredients division of IFF
Acquiror:
Exponent Private Equity
Sole financial adviser to Exponent, one of the UK’s leading private equity firms, on the acquisition of IFF’s Flavor Specialty Ingredients division, a global leader in the base aromas market
23-Jan-23
Pending
$200 million
Target:
Clinigen Ltd’s Proleukin
Acquiror:
Iovance Biotherapeutics
Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies
30-Dec-22
$153 million
Target:
Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products
Acquiror:
Mayne Pharma
Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma
28-Dec-22
Pending
Undisclosed
Target:
Eisai Distribution Co., Ltd.
Acquiror:
Yasuda Logistics Corporation
Advising Eisai, a Japanese pharmaceutical company, on the sale of Eisai Distribution, a 100% shares holding logistic subsidiary, to Yasuda Logistics Corporation, a Japanese logistic company conducting total logistic services such as Warehousing, Transportation, delivery and forwarding, and Port transportation business, etc.
29-Nov-22
Undisclosed
Target:
Staff Brain Co., Ltd. And Technobrain Co., Ltd.
Acquiror:
World Co., LTD.
World Co., LTD. ("World"), a regional staffing company in Japan, acquired Brain Group (Staff Brain Co., Ltd. and Technobrain Co., Ltd.), regional staffing companies in Japan
24-Nov-22
Pending
Undisclosed
Target:
Kyowa Kirin International’s established medicines business
Acquiror:
Grünenthal
Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on a collaboration agreement with Grünenthal GmbH, a global, science-based, privately-owned pharmaceutical company
03-Nov-22
Undisclosed
Target:
Pixelligent Technologies
Acquiror:
MVolution Partners
Advised Pixelligent Technologies, a leading manufacturer of nanocrystal material used in consumer electronic devices, on its growth capital raise
02-Nov-22
Undisclosed
Target:
Medallion Delaware Basin, LLC
Acquiror:
Cardinal Midstream Partners
Advised Medallion Midstream and The Energy & Minerals Group on the sale of Medallion Delaware, a newly-built natural gas gathering & processing system in the heart of the Delaware Basin, to Cardinal Midstream Partners
25-Oct-22
Pending
Undisclosed
Target:
Acreage Holdings
Acquiror:
Canopy Growth Corporation
Advising Canopy Growth, a leading diversified cannabis company, on the re-organization and consolidation of its U.S. cannabis assets under a new holding company, Canopy USA, and on related investments and debt repurchase transactions